Loading clinical trials...
Loading clinical trials...
A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects With Ulcerative Colitis
Conditions
Interventions
Filgotinib
Placebo
Locations
323
United States
Digestive Health Specialists Of The Southeast
Dothan, Alabama, United States
Mayo Clinic Arizona
Scottsdale, Arizona, United States
VA Long Beach Healthcare System
Long Beach, California, United States
Cedars Sinai Medical Center
Los Angeles, California, United States
South Denver Gastroenterology, PC
Lone Tree, Colorado, United States
Connecticut GI PC-Research Division
Farmington, Connecticut, United States
Start Date
February 23, 2017
Primary Completion Date
September 1, 2026
Completion Date
September 1, 2026
Last Updated
February 6, 2025
NCT07550673
NCT07374471
NCT06071312
NCT05739864
NCT04338204
NCT07271069
Lead Sponsor
Alfasigma S.p.A.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions